Steven Cohen's EVMN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 36,577 shares of Evommune, Inc. (EVMN) worth $840,905, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in EVMN, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 2,193 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Evommune (EVMN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Evommune (EVMN) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +2,193 | Add 6.38% | 36,577 | $22.99 |
| Q4 2025 | +34,384 | New Buy | 34,384 | $17.12 |
Steven Cohen's Evommune Investment FAQs
Steven Cohen first purchased Evommune, Inc. (EVMN) in Q4 2025, acquiring 34,384 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Evommune, Inc. (EVMN) for 2 quarters since Q4 2025.
Steven Cohen's largest addition to Evommune, Inc. (EVMN) was in Q4 2025, adding 34,384 shares worth $588,654.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 36,577 shares of Evommune, Inc. (EVMN), valued at approximately $840,905.
As of the Q1 2026 filing, Evommune, Inc. (EVMN) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Evommune, Inc. (EVMN) was 36,577 shares, as reported at the end of Q1 2026.